UNIP5
PNAconsolidatedUNIPAR CARBOCLORO S.A.
CNPJ 33958695000178
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Distributions
| Type | Approved on | Ex-date basis | R$ / share |
|---|---|---|---|
| DIVIDENDO | 2025-12-02 | 2025-12-05 | 6.030423 |
| DIVIDENDO | 2025-12-02 | 2025-12-05 | 0.446379 |
| DIVIDENDO | 2025-08-07 | 2025-08-12 | 0.142401 |
| DIVIDENDO | 2025-08-07 | 2025-08-12 | 3.558629 |
| DIVIDENDO | 2025-03-13 | 2025-03-18 | 2.297910 |
| DIVIDENDO | 2024-11-13 | 2024-11-19 | 2.164294 |
| DIVIDENDO | 2024-11-13 | 2024-11-19 | 0.575244 |
| DIVIDENDO | 2024-03-14 | 2024-03-19 | 0.400061 |
| DIVIDENDO | 2024-03-14 | 2024-03-19 | 1.082854 |
| DIVIDENDO | 2023-12-13 | 2023-12-18 | 1.563259 |
| DIVIDENDO | 2023-04-20 | 2023-04-20 | 1.091236 |
| DIVIDENDO | 2023-04-20 | 2023-04-20 | 0.893253 |
Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5.14bn | 481.74m | 28.5% | 9.4% | 26.5% | 6.7% | 0.71 | 62.00 | 13.75 | 20.1% |
| 2024 | 5.43bn | 557.12m | 27.1% | 10.3% | 19.8% | 7.8% | 0.76 | 48.51 | 9.32 | — |
| 2023 | 4.90bn | 791.27m | 34.7% | 16.2% | 32.3% | 12.4% | 0.77 | 78.97 | — | 4.5% |
| 2022 | 7.27bn | 1.33bn | 44.8% | 18.4% | 56.7% | 22.3% | 1.21 | 93.67 | 6.90 | — |
| 2021 | 6.29bn | 2.00bn | 44.6% | 31.9% | 86.3% | 32.1% | 1.01 | 102.90 | — | 15.0% |
| 2020 | 3.87bn | 370.22m | 34.5% | 9.6% | 21.3% | 8.2% | 0.86 | 48.80 | 12.25 | 3.1% |
| 2019 | 3.05bn | 172.36m | 26.8% | 5.7% | 11.6% | 4.6% | 0.82 | 35.95 | 18.76 | — |
| 2018 | 3.47bn | 547.44m | 36.3% | 15.8% | 37.9% | 13.5% | 0.86 | 37.45 | — | — |
| 2017 | 3.02bn | 306.26m | 30.0% | 10.1% | 28.6% | 8.8% | 0.87 | 16.35 | 4.22 | 31.2% |
| 2016 | 889.71m | 280.84m | 43.6% | 31.6% | 21.8% | 8.0% | 0.25 | 8.00 | 2.22 | 5.8% |
| 2012 | 355.39m | 39.28m | 41.3% | 11.1% | 9.5% | 5.1% | 0.46 | 0.52 | 10.72 | 0.4% |
| 2011 | 345.35m | 4.45m | 38.8% | 1.3% | 1.2% | 0.5% | 0.39 | 0.65 | — | — |
| 2010 | 316.23m | 30.30m | 38.7% | 9.6% | 8.1% | 3.0% | 0.31 | — | — | — |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
The table is entirely consolidated — the side that closes the most recent 12 months. The fiscal years 2013, 2014, 2015 exist only on the standalone side and are left out: mixing both sides in one column would compare figures of different natures.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 1.50bn | 300.48m | 123.32m | 8.2% |
| Q1 26 | 1.24bn | 84.97m | 37.25m | 3.0% |
| Q4 25 | 1.24bn | 40.01m | -7.37m | -0.6% |
| Q3 25 | 1.26bn | 186.06m | 107.26m | 8.5% |
| Q2 25 | 1.27bn | 311.78m | 231.50m | 18.2% |
| Q1 25 | 1.37bn | 255.68m | 150.35m | 11.0% |
| Q4 24 | 1.64bn | 342.30m | 292.74m | 17.9% |
| Q3 24 | 1.38bn | 129.82m | 118.95m | 8.6% |
| Q2 24 | 1.25bn | 35.63m | 89.54m | 7.1% |
| Q1 24 | 1.17bn | 117.27m | 55.90m | 4.8% |
| Q4 23 | 643.61m | 20.17m | 161.18m | 25.0% |
| Q3 23 | 1.37bn | 214.84m | 190.79m | 14.0% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 7.76bn | 2.01bn | 3.86 | 2.39 |
| Q1 26 | 7.46bn | 1.89bn | 3.95 | 2.09 |
| Q4 25 | 7.23bn | 1.82bn | 3.98 | 2.29 |
| Q3 25 | 7.63bn | 2.48bn | 3.07 | 3.18 |
| Q2 25 | 7.54bn | 2.83bn | 2.67 | 2.96 |
| Q1 25 | 7.28bn | 2.67bn | 2.73 | 2.24 |
| Q4 24 | 7.11bn | 2.81bn | 2.53 | 2.88 |
| Q3 24 | 7.58bn | 2.78bn | 2.72 | 2.26 |
| Q2 24 | 7.16bn | 2.70bn | 2.65 | 2.52 |
| Q1 24 | 7.10bn | 2.56bn | 2.78 | 2.73 |
| Q4 23 | 6.40bn | 2.45bn | 2.61 | 2.36 |
| Q3 23 | 6.20bn | 2.84bn | 2.19 | 1.92 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-06 | 37 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-14 | 44 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-19 | 78 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-13 | 44 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-07 | 38 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-08 | 38 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-13 | 72 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-13 | 44 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-08 | 39 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-09 | 39 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-03-14 | 74 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-09 | 40 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-10 | 41 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-11 | 41 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-03-20 | 79 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-10 | 41 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.